Hemorrhoid Artery Embolization (HAE) for Bleeding Internal Hemorrhoids: A Real-World Registry
Official title: Creation Of a Prospective Registry For Hemorrhoid Artery Embolization At The Joint & Vascular Institute
Run by Joint & Vascular Institute · NCT07635784 · Data updated 2026-11-12
This registry collects real-world data to see if hemorrhoid artery embolization helps adults with symptomatic internal hemorrhoids that haven’t improved with standard care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Joint & Vascular Institute Industry-sponsored |
| Locations | 1 site (Libertyville, Illinois) |
| Status | Recruiting |
| Started | January 18, 2026 |
| Main results expected | January 2031 |
| Study ends | January 2032 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07635784 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with symptomatic internal hemorrhoids that bleed and have not responded to medical therapy, referred for HAE.
✕Probably not a fit
Patients with contraindications to embolization, non-bleeding hemorrhoids, or those who cannot consent or be followed for 36 months may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective registry records long-term outcomes of patients undergoing hemorrhoid artery embolization (HAE) for symptomatic internal hemorrhoidal bleeding. Participants are adults 18 and older who have not responded to medical therapy and are treated as part of routine care. Follow-up occurs at 1, 3, 6, 12, 18, 24, and 36 months to track bleeding, symptoms, and quality of life, with safety data collected per interventional radiology guidelines. There is no randomized control group; analyses will identify predictors of success and help refine patient selection and best practices for HAE. The study is observational and aims to understand real-world effectiveness and safety of HAE in this population.
Why it matters
Potential benefit: If successful, the registry could clarify who benefits most from HAE and improve patient selection and care pathways.
How similar studies have gone: Previous interventional studies suggest potential benefit of HAE, but evidence in a real-world registry context is still evolving; this registry aims to add real-world data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years) with symptomatic bleeding internal hemorrhoids refractory to medical therapy, referred for HAE. Exclusion Criteria: * Pregnancy, coagulopathy, severe comorbidities, or inability to consent.
Where it's running
-
Joint and Vascular Institute
Libertyville, Illinois, United States Recruiting
Study contacts
- Study coordinator: Layth Alkhani, BS
- Email: lalkhani@jointvascular.com
- Phone: 847-584-3959
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Topical nifedipine 0.3% plus lidocaine 1.5% for uncomplicated hemorrhoids
This will try topical nifedipine 0.3% plus lidocaine 1.5% applied rectally and perianally twice daily to reduce symptoms in adults with uncomplicated acute hemorrhoids.
-
Comparing latex and non-latex bands for treating hemorrhoids
This study is testing whether non-latex bands work as well as latex bands for treating hemorrhoids in adults and looking at any side effects they might cause.
-
SHAPE vs. Milligan-Mordon hemorrhoidectomy for advanced hemorrhoids
This trial tests whether Skin-Sparing Hemorrhoidectomy and PExy (SHAPE) works as well as the conventional Milligan-Morgan procedure for adults with severe hemorrhoids.
-
Hemorrhoidal artery embolization versus rubber band ligation for internal hemorrhoid bleeding
This trial will test whether hemorrhoidal artery embolization or rubber band ligation better stops bleeding and improves symptoms in adults with internal hemorrhoids.
-
Laser hemorrhoidoplasty outcomes in internal hemorrhoids
This study tests how patients with symptomatic internal hemorrhoids fare after laser hemorrhoidoplasty, focusing on pain, complications, and satisfaction after the procedure.
-
Energy-based therapies vs standard surgery for Grade III hemorrhoids
This trial tests three surgical options—two energy-based methods and conventional hemorrhoidectomy—to see which relieves pain and helps people recover fastest.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.